GAROFALO ELIZABETH A.

CIK 00018263614 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001826361

Recent Transactions

50 trades

Award
Alector, Inc.$ALEC
Stock Option (right to buy)
2026-06-17+9,450→ 9,450 total
Award
Alector, Inc.$ALEC
Common Stock
2026-06-17+28,700→ 118,650 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2026-06-03+10,507→ 10,507 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2026-06-03+1,593→ 1,593 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2026-06-01−2,645→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-06-01+2,645→ 2,645 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2026-05-29+8,107→ 33,489 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2026-05-29+9,311→ 9,311 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2026-05-29+16,004→ 16,004 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2026-05-29−8,107→ 0 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-09-02$25.98/sh−1,600→ 25,382 total
Award
Alector, Inc.$ALEC
Stock Option (right to buy)
2025-06-11+9,450→ 9,450 total
Award
Alector, Inc.$ALEC
Common Stock
2025-06-11+28,700→ 89,950 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2025-06-05+2,645→ 2,645 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2025-06-05+17,012→ 17,012 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-05-29+8,107→ 8,107 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-05-29+9,387→ 26,982 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-05-29−9,387→ 0 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2025-05-29+13,793→ 13,793 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-03-05$18.23/sh−4,919→ 17,595 total
Award
Alector, Inc.$ALEC
Common Stock
2024-06-12+35,000→ 61,250 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-06-05+15,542→ 15,542 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-29+6,652→ 22,514 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2024-05-29+15,959→ 15,959 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-29+9,387→ 9,387 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-29−6,652→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-08$18.56/sh+3,500→ 3,500 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-08$46.16/sh−1,408→ 2,092 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-08$45.69/sh−2,092→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-03-08−3,500→ 16,500 total
Gift
Alector, Inc.$ALEC
Common Stock
2023-12-05−9,459→ 26,250 total
Gift
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-11-24−2,918→ 15,862 total
Award
Alector, Inc.$ALEC
Common Stock
2023-06-14+26,250→ 35,709 total
Award
Alector, Inc.$ALEC
Stock Option (right to buy)
2023-06-14+12,360→ 12,360 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-06-02+18,475→ 18,475 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-06-01−8,552→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-06-01+8,552→ 18,780 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-06-01+6,652→ 6,652 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2023-06-01+11,045→ 11,045 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2022-09-29−1,919→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2022-09-29+1,919→ 10,228 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-06-28+18,000→ 18,000 total
Award
Alector, Inc.$ALEC
Common Stock
2022-06-16+9,459→ 9,459 total
Award
Alector, Inc.$ALEC
Stock Option (right to buy)
2022-06-16+18,918→ 18,918 total
Award
EXICURE, INC.$XCUR
Employee Stock Option (right to buy)
2022-06-13+50,000→ 50,000 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2022-06-07−6,391→ 0 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2022-06-07+8,552→ 8,552 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2022-06-07+14,368→ 14,368 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2022-06-07+6,391→ 8,309 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2021-09-29+1,918→ 1,918 total

Companies

Recent Filings

Address

C/O ALECTOR, INC. 131 OYSTER POINT BLVD., SUITE 600

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov